Search Results 1981-1990 of 16126 for Epilepsy (Partial Onset)

  1. Publications - Brian A. Neff, M.D. - Mayo Clinic

    New onset tinnitus in the absence of hearing changes following COVID-19 infection. Am J Otolaryngol. 2022 Jan-Feb; 43 (1):103208 Epub 2021 Sept 10. View ...

  2. Publications - John A. Stauffer, M.D. - Mayo Clinic

    Late onset asymptomatic pancreatic neuroendocrine tumor - A case report on ... Laparoscopic partial sleeve duodenectomy (PSD) for nonampullary duodenal ...

  3. Publications - Gregory A. Broderick, M.D. - Mayo Clinic

    Epub 2016 Oct 19. View PubMed; Davidiuk AJ, Broderick GA. Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. Transl Androl ...

  4. Ocular Hypertension Treatment Study (OHTS) - Mayo Clinic

    To determine whether medical reduction of intraocular pressure prevents or delays the onset of glaucomatous visual field loss and/or optic disc damage in ...

  5. Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice - Mayo Clinic

    Syncope or seizure that preceded (led to) head trauma; Patient known to be pregnant; Neuroimaging at an outside hospital before transfer; Patient has 3 or more ...

  6. Publications - Erin E. Knoebel, M.D., M.P.H. - Mayo Clinic

    Outcomes of Adolescent-Onset Postural Orthostatic Tachycardia Syndrome. J Pediatr. 2016 Jun; 173:149-53 Epub 2016 Mar 12. View PubMed; Egginton JS, Textor L ...

  7. Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer - Mayo Clinic

    ... duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she must inform her treating ...

  8. Study of Pembrolizumab With Ipilimumab or Placebo in Participants with Untreated Metastatic Non-small Cell Lung Cancer - Mayo Clinic

    The primary hypothesis of this study is that overall survival (OS) and/or progression-free survival (PFS) is prolonged in participants who receive pembrolizumab ...

  9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    Diagnostic criteria must be fulfilled for the last 3 months, with symptom onset at least 6 months before diagnosis. Subtyping performed by the predominant ...

  10. Neuropathies Clinical Trials - Mayo Clinic Research

    This study will determine the effect of QPI-1007 on visual function in subjects with recent-onset ... A secondary goal is to determine the duration of pain relief ...